Series A Completed

Kanvas Biosciences Series A

US$48m raised

Announced 6 May 2026

Investors

Led by

With

  • Gates Foundation

Investors as the sources name them; a linked name has a FundComb profile.

Company
Kanvas Biosciences
Stage
Series A
Amount raised
US$48m
Company based in
United States
Sector
Biotech
Tags
Biotech, Drug Development

Similar rounds

All Series A rounds →

Sources

Suggest a correction

A missing investor, a different lead, amount or date. A link to a public source helps.